GR1008468B - Cisplatin mixture in the form of inhaled dry finely-granulated powder - Google Patents

Cisplatin mixture in the form of inhaled dry finely-granulated powder

Info

Publication number
GR1008468B
GR1008468B GR20140100125A GR20140100125A GR1008468B GR 1008468 B GR1008468 B GR 1008468B GR 20140100125 A GR20140100125 A GR 20140100125A GR 20140100125 A GR20140100125 A GR 20140100125A GR 1008468 B GR1008468 B GR 1008468B
Authority
GR
Greece
Prior art keywords
mixture
granulated powder
dry finely
inhaled dry
cisplatin
Prior art date
Application number
GR20140100125A
Other languages
Greek (el)
Inventor
Κωνσταντινος Παυλου Ζαρογουλιδης
Original Assignee
Κωνσταντινος Παυλου Ζαρογουλιδης
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Κωνσταντινος Παυλου Ζαρογουλιδης filed Critical Κωνσταντινος Παυλου Ζαρογουλιδης
Priority to GR20140100125A priority Critical patent/GR1008468B/en
Publication of GR1008468B publication Critical patent/GR1008468B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention relates to the preparation of Cisplatin mixture (cis-diamminedichloroplatinum-complex heavy metal solution) containing a single platinum atom. The drastic component is a yellow-to-orange coloured powder characterized in having the molecule formula of Ptcl2H6N2, the cellular weight of 300,1 and monohydric lactose in the form of inhaled dry finely-granulated powder of 2,5μm (1,2 to 5,5μm) average diameter. The precise composition of the mixture enables the direct administration of the medication through the respiratory tract and its direct conveyance in the interior lumen of thelung's airways for efficiently facing grave lung diseases.
GR20140100125A 2014-03-12 2014-03-12 Cisplatin mixture in the form of inhaled dry finely-granulated powder GR1008468B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20140100125A GR1008468B (en) 2014-03-12 2014-03-12 Cisplatin mixture in the form of inhaled dry finely-granulated powder

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20140100125A GR1008468B (en) 2014-03-12 2014-03-12 Cisplatin mixture in the form of inhaled dry finely-granulated powder

Publications (1)

Publication Number Publication Date
GR1008468B true GR1008468B (en) 2015-04-22

Family

ID=53178004

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20140100125A GR1008468B (en) 2014-03-12 2014-03-12 Cisplatin mixture in the form of inhaled dry finely-granulated powder

Country Status (1)

Country Link
GR (1) GR1008468B (en)

Similar Documents

Publication Publication Date Title
WO2013021199A3 (en) Eutectic mixture for pulmonary administration
TN2015000395A1 (en) Respirable agglomerates of porous carrier particles and micronized drug
SA520411119B1 (en) Liposome Compositions Comprising Weak Acid Drugs and Uses Thereof
PH12014502662A1 (en) Novel dosage form and formulation of abediterol
PH12017502087B1 (en) Tiotropium inhalation solution for nebulization
WO2014016548A3 (en) Pharmaceutical composition comprising olodaterol and one or more further active pharmaceutical ingredient
EA201291306A1 (en) COMPOSITION OF DRY POWDER CONTAINING ANTIMUSCARINE MEANS
EA201590030A1 (en) DRY POWDER INHALERS, CONTAINING CARRIER, EXCELLENT FROM LACTOSE, AND THIRD COMPONENT
NZ705260A (en) Aerosol pirfenidone and pyridine analog compounds for the treatment of lung disease
MX2015015132A (en) Inhalable pharmaceutical compositions and the inhaler devices containing them.
WO2014007772A3 (en) Inhalation compositions comprising glucose anhydrous
WO2014007770A3 (en) Inhalation compositions comprising corticosteroid and sorbitol
EP2682097A3 (en) Dry Powder Inhalers Comprising A Carrier Other Than Lactose
WO2014007781A3 (en) Inhalation compositions
MD20140131A2 (en) Novel dosage and formulation for inhalation comprising aclidinium
MX2017013950A (en) Zolmitriptan powders for pulmonary delivery.
WO2014007771A3 (en) Inhalation compositions comprising muscarinic receptor antagonist
UA118192C2 (en) ANTI-VIRUS PHARMACEUTICAL COMPOSITION
MX2015015150A (en) Inhalable pharmaceutical compositions and the inhaler devices containing them.
NZ702835A (en) 3-o-heteroaryl-ingenol
UA115989C2 (en) Dry powder inhaler compositions comprising long acting muscorinic antagonists
MX2021011491A (en) Inhalable dry powders.
EA032975B1 (en) Pharmaceutical composition comprising a cyclic peptide of formula x-gqretpegaeakpwy-xand use for extracorporeal lung treatment
MX2020010977A (en) Methods of treating fungal infections.
GR1008468B (en) Cisplatin mixture in the form of inhaled dry finely-granulated powder

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20150518